Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03764033 · ClinicalTrials.gov registry record · NA
A Novel Posttraumatic Stress Disorder Treatment for Veterans With Moral Injury
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03764033: Completed NA study, sponsored by VA Office of Research and Development.
NCT03764033 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03764033, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The objective of this project is to test the efficacy of an individual treatment for post-traumatic stress disorder (PTSD) stemming from moral injury called Impact of Killing (IOK), compared to a present-centered therapy (PCT) control condition, and to determine the rehabilitative utility of IOK for Veterans with PTSD. The first aim is to test whether IOK can help improve psychosocial functioning for Veterans, as well as PTSD symptoms. The second aim is to determine whether IOK gains made by Veterans in treatment are durable, as measured by a six-month follow-up assessment. Veterans who kill in war are at increased risk for functional difficulties, PTSD, alcohol abuse, and suicide. Even after current PTSD psychotherapies, most Veterans continue to meet diagnostic criteria for PTSD, highlighting the need for expanding treatments for PTSD and functioning. IOK is a treatment that can be provided following existing PTSD treatments, filling a critical gap for Veterans with moral injury who continue to suffer from mental health symptoms and functional difficulties.
Interventions
- BEHAVIORAL Present Centered Therapy
- BEHAVIORAL Impact of Killing (IOK)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-08-12 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03764033
The ClinicalTrials.gov registry entry for NCT03764033 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Present Centered Therapy is the first listed.
NCT03764033 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03764033 about?
NCT03764033 is a clinical study titled "A Novel Posttraumatic Stress Disorder Treatment for Veterans With Moral Injury". The objective of this project is to test the efficacy of an individual treatment for post-traumatic stress disorder (PTSD) stemming from moral injury called Impact of Killing (IOK), compared to a present-centered therapy (PCT) control condition, and to determine the rehabilitative utility of IOK for...
What is the current status of trial NCT03764033?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2019-08-12. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT03764033?
The interventions under investigation include: Present Centered Therapy (BEHAVIORAL), Impact of Killing (IOK) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03764033?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.